TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Leo Pharma AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 149,327 | 169,073 | 197,194 |
Financial expenses | 2,198 | 408 | 601 |
Earnings before taxes | 5,860 | 7,630 | 8,892 |
EBITDA | 6,192 | 8,096 | 9,301 |
Total assets | 125,092 | 203,670 | 106,714 |
Current assets | 117,587 | 188,907 | 90,766 |
Current liabilities | 77,431 | 95,407 | 55,205 |
Equity capital | 28,200 | 24,851 | 20,444 |
- share capital | 946 | 975 | 1,048 |
Employees (average) | 18 | 31 | 35 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 22.5% | 12.2% | 19.2% |
Turnover per employee | 8,296 | 5,454 | 5,634 |
Profit as a percentage of turnover | 3.9% | 4.5% | 4.5% |
Return on assets (ROA) | 6.4% | 3.9% | 8.9% |
Current ratio | 151.9% | 198.0% | 164.4% |
Return on equity (ROE) | 20.8% | 30.7% | 43.5% |
Change turnover | -14,665 | -14,497 | -11,887 |
Change turnover % | -9% | -8% | -6% |
Chg. No. of employees | -13 | -4 | 1 |
Chg. No. of employees % | -42% | -11% | 3% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.